ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 68 filers reported holding ADMA BIOLOGICS INC in Q2 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $184,000 | -79.0% | 115,100 | -76.9% | 0.12% | -84.0% |
Q1 2021 | $876,000 | -49.1% | 497,842 | -43.6% | 0.72% | -9.9% |
Q4 2020 | $1,722,000 | +34.5% | 883,214 | +65.0% | 0.80% | +30.7% |
Q3 2020 | $1,280,000 | -66.4% | 535,324 | -58.8% | 0.61% | -62.7% |
Q2 2020 | $3,807,000 | +6.4% | 1,299,300 | +4.6% | 1.63% | -2.3% |
Q1 2020 | $3,579,000 | +46.7% | 1,242,700 | +126.6% | 1.67% | +23.7% |
Q3 2019 | $2,440,000 | +239.4% | 548,409 | +195.3% | 1.35% | +272.7% |
Q2 2019 | $719,000 | – | 185,721 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |